19 results
424B3
PTPI
Petros Pharmaceuticals Inc
14 Jan 22
Prospectus supplement
5:18pm
or clinical trials, which could result in regulatory sanctions and cause serious harm to Petros’ reputation.
Additionally, Petros is subject to the risk … proprietary and confidential information, which could harm our business and reputation or cause us to incur increased expenses to address any
424B5
8hfdyg
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
rd6a0zk8
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
8ocvgk5wr1wsjqu
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
z630fty9fkwe2b
31 Mar 21
Annual report
4:30pm
S-3
3nl2hwql 6y
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
qzzocj4
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
424B3
tjhcm63x
2 Nov 20
Prospectus supplement
12:00am
S-4/A
xr9ho6r7
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
zxqniiyujo52
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next